IGF2 anticorps (AA 25-180)
-
- Antigène Voir toutes IGF2 Anticorps
- IGF2 (Insulin-Like Growth Factor 2 (IGF2))
-
Épitope
- AA 25-180
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp IGF2 est non-conjugé
-
Application
- Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
- Fonction
- IGF2 Antibody
- Purification
- Purified antibody
- Immunogène
- Purified recombinant fragment of human IGF2 (AA: 25-180) expressed in E. Coli.
- Clone
- 8H1
- Isotype
- IgG1
-
-
- Indications d'application
-
ELISA: 1/10000
FCM: 1/200 - 1/400
ICC: 1/200 - 1/1000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients." dans: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, Vol. 16, Issue 4, pp. 346-54, (2011) (PubMed).
: "Regulation of IGF2 transcript and protein expression by altered methylation in breast cancer." dans: Journal of cancer research and clinical oncology, Vol. 137, Issue 2, pp. 339-45, (2011) (PubMed).
: "
-
Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients." dans: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, Vol. 16, Issue 4, pp. 346-54, (2011) (PubMed).
-
- Antigène
- IGF2 (Insulin-Like Growth Factor 2 (IGF2))
- Autre désignation
- IGF2 (IGF2 Produits)
- Synonymes
- anticorps C11orf43, anticorps IGF-II, anticorps PP9974, anticorps LOC100136550, anticorps igf2, anticorps igf2b, anticorps wu:fc26e03, anticorps zgc:91781, anticorps igf-2, anticorps insigf, anticorps pp9974, anticorps AL033362, anticorps Igf-2, anticorps Igf-II, anticorps M6pr, anticorps Mpr, anticorps Peg2, anticorps IGFII, anticorps RNIGF2, anticorps IGF-II-B, anticorps igf2-a, anticorps igf2-b, anticorps insulin like growth factor 2, anticorps insulin-like growth factor II, anticorps insulin-like growth factor 2a, anticorps insulin like growth factor 2 S homeolog, anticorps insulin-like growth factor 2, anticorps insulin-like growth factor 2 (somatomedin A), anticorps insulin like growth factor 2 L homeolog, anticorps IGF2, anticorps LOC100136550, anticorps igf2a, anticorps igf2.S, anticorps Igf2, anticorps igf2.L
- Sujet
-
Description: This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Aliases: IGF-II, PP9974, C11orf43, FLJ22066, FLJ44734
- Poids moléculaire
- 20.1kDa
- ID gène
- 3481
- HGNC
- 3481
- UniProt
- P01344
- Pathways
- Hormone Activity, Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, Regulation of Carbohydrate Metabolic Process, Activated T Cell Proliferation
-